HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pauline Maiello Selected Research

Tuberculosis (Tuberculoses)

11/2023Intravenous Bacille Calmette-Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis.
1/2023Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens.
1/2023Mycobacterium tuberculosis-Specific CD4 T Cells Expressing Transcription Factors T-Bet or RORγT Associate with Bacterial Control in Granulomas.
1/2023Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques.
1/2023Blood transcriptional correlates of BCG-induced protection against tuberculosis in rhesus macaques.
1/2022Macrophages and neutrophils express IFNλs in granulomas from Mycobacterium tuberculosis-infected nonhuman primates.
1/2020Prevention of tuberculosis in macaques after intravenous BCG immunization.
1/2020IL-10 Impairs Local Immune Response in Lung Granulomas and Lymph Nodes during Early Mycobacterium tuberculosis Infection.
1/2020Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques.
1/2019Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pauline Maiello Research Topics

Disease

18Granuloma
12/2023 - 01/2015
18Tuberculosis (Tuberculoses)
11/2023 - 12/2014
15Infections
03/2024 - 01/2016
6Inflammation (Inflammations)
03/2024 - 01/2016
4Reinfection
03/2024 - 10/2018
2Coinfection
03/2024 - 12/2023
2Pulmonary Tuberculosis
11/2023 - 01/2020
2Pneumonia (Pneumonitis)
01/2017 - 01/2017
1Fibrosis (Cirrhosis)
01/2020
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2020
1Bradycardia
03/2017
1Hypotension (Low Blood Pressure)
03/2017
1Cytokine Release Syndrome
01/2017
1Influenza in Birds (Avian Flu)
01/2017
1Extensively Drug-Resistant Tuberculosis
12/2014

Drug/Important Bio-Agent (IBA)

9CytokinesIBA
03/2024 - 01/2015
9VaccinesIBA
11/2023 - 01/2017
6Anti-Bacterial Agents (Antibiotics)IBA
03/2024 - 12/2014
5AntigensIBA
01/2023 - 01/2015
4Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2015
3RNA (Ribonucleic Acid)IBA
12/2023 - 10/2022
3Interleukin-10 (Interleukin 10)IBA
01/2020 - 01/2016
3Interleukin-17 (Interleukin 17)IBA
01/2016 - 01/2015
2LigandsIBA
12/2023 - 01/2017
2Transcription Factors (Transcription Factor)IBA
01/2023 - 01/2022
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2017
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021 - 01/2017
2Linezolid (Zyvox)FDA Link
01/2020 - 12/2014
2Granzymes (Granzyme)IBA
01/2020 - 08/2015
2Interleukin-2 (IL2)IBA
01/2016 - 01/2016
1Interleukin-15 (Interleukin 15)IBA
12/2023
1Moxifloxacin (Avelox)FDA Link
01/2023
1Immunodominant EpitopesIBA
01/2023
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
01/2021
1BCG VaccineFDA Link
01/2020
1Interleukin-1 (Interleukin 1)IBA
01/2020
1Rifampin (Rifampicin)FDA LinkGeneric
01/2020
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2020
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2020
1AerosolsIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
10/2018
1Hypnotics and Sedatives (Sedatives)IBA
03/2017
1Xylazine (Xylazin)IBA
03/2017
1Yohimbine (Yocon)IBA
03/2017
1atipamezoleIBA
03/2017
1IntegrinsIBA
01/2017
1PeptidomimeticsIBA
01/2017
1AlbuminsIBA
01/2017
1Tuberculosis VaccinesIBA
01/2017
1Integrin alpha4beta1 (VLA-4)IBA
01/2017
1Rituximab (Mabthera)FDA Link
01/2016
1Interleukin-6 (Interleukin 6)IBA
01/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016
1Neutralizing AntibodiesIBA
01/2016
1PerforinIBA
08/2015
1LipopolysaccharidesIBA
08/2015
1EnzymesIBA
08/2015
1Oxazolidinones (2 Oxazolidone)IBA
12/2014
1Therapeutic UsesIBA
12/2014

Therapy/Procedure

2Therapeutics
01/2023 - 01/2020
1Intravenous Administration
01/2020